GlaxoSmithKline set to exit Nigeria after 51 years of operation
GlaxoSmithKline (GSK), a British pharmaceutical and biotechnology company, has announced its plan to exit Nigeria after 51 years of operation in Nigeria.
However, GSK Nigeria, in a statement by its secretary, Fredrick Ichekwai, said the exit would be in the coming months. The statement was sent to the Nigeria Exchange Limited (NGX).
The company said it resolved to exit the West African country after its board meeting and evaluation of options with GSK UK.
“The board of GlaxoSmithKline Consumer Nigeria Plc has concluded that there is no alternative but to cease operations,” GSK Nigeria said.
The development comes two months after the company lamented the difficulty in accessing currency, stating that it affected its supply of products to Nigeria.
“The challenge in accessing currency is affecting our ability to maintain a consistent supply of medicines and vaccines in the market,” it said in a statement by its spokesperson, Omongiade Ehighebolo.
Nonetheless, the company, in its latest statement, said it would appoint third-party distributors to supply medicines and healthcare products in Nigeria.
“The Haleon Group has also separately informed the board of its intent to terminate its distribution agreement in the coming months and to appoint a third-party distributor in Nigeria for the supply of its consumer healthcare products,” it said.
GSK Nigeria said it would ensure it meets legal requirements on the development with its employees and shareholders.
It advised shareholders to seek professional advice and exercise caution when dealing with the company’s shares until a further announcement.
“The Board is conscious that shareholders will have many questions; we have been working assiduously with our professional advisors to agree on the next steps, and we will be shortly submitting to the Securities and Exchange Commission (“SEC”) a draft Scheme of Arrangement which may if approved, see shareholders other than GSK UK, receive an accelerated cash distribution and return of capital,” it said.
GlaxoSmithKline Consumer Nigeria Plc was incorporated in Nigeria on June 23, 1971, and commenced business on July 1, 1972, under Beecham Limited.
The company was quoted on the Nigerian Stock Exchange in 1977.
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette
Agriculture
FG tasks ECOWAS on leveraging financing strategies for agroecology
The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices
Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”
Africa
Ebola cases rise as outbreak expands to 63 health zones in DR Congo: WHO
WHO said delays in diagnosis and access to adequate treatment could contribute to preventable deaths.
States
Edo govt. targets jobs, revenue through tourism, hospitality sectors
Mr Okaeben said the state government was committed to creating an enabling environment where talents could thrive.
NationWide
Army trains 380 personnel in specialised skills to boost operations
Mr Adejimi said the training was designed to improve the technical capabilities of personnel.
States
Police nab two suspects for alleged car theft in Niger village
The suspected soldier and one other took to their heels, while the other two were arrested.
States
Niger: Police detain security guard over alleged defilement, death of minor
Mr Abiodun said Mr Dauda allegedly confessed during interrogation to luring the girl into his security room.
NationWide
Morka’s gutter language cannot bury Tinubu’s drug record: ADC Campaign Council
The council also challenged the APC to explain inconsistencies in Mr Tinubu’s educational records.
